Press Release Details

MELVILLE, N.Y., Jan. 12, 2016 /PRNewswire/ -- Henry Schein, Inc. (NASDAQ: HSIC), the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners, announced today an agreement to acquire RxWorks, Inc., a provider of veterinary practice management software primarily to customers in Australia, New Zealand, the UK and the Netherlands, and other countries around the world.

RxWorks had sales for the 12 months ended June 30, 2015 of approximately $7 million. Henry Schein expects the acquisition to close in the second half of January 2016, and to be dilutive by less than $0.01 to 2016 earnings per share, and accretive to 2017 earnings per share by approximately $0.01. Financial details and terms of the transaction were not disclosed.

Founded in 1988 with headquarters in Brisbane, Queensland, Australia, RxWorks has 68 Team Members and an installed base of more than 1,500 veterinary clinics in 19 countries worldwide. RxWorks will continue to be led by its current management team. Upon closing, RxWorks will become part of Henry Schein's Global Animal Health Practice Solutions business.

"RxWorks has an excellent reputation for helping veterinarians increase practice efficiency and improve quality health care through its innovative practice management software solutions," said Stanley M. Bergman, Chairman of the Board and Chief Executive Officer, Henry Schein, Inc. "The addition of RxWorks further strengthens our growing practice management software solutions business, which helps deepen relationships in the regions served by RxWorks with our animal health customers, including large corporate customers. The addition of RxWorks will nicely complement our expanding animal health technology businesses. We look forward to welcoming our new colleagues from RxWorks to Henry Schein."

RxWorks provides veterinary practices with software solutions and content that address clinical and business needs, such as billing, automatic appointment reminders, and tracking of patient progress through the practice workflow to avoid inefficiency. RxWorks is committed to ensuring that its software remains relevant by monitoring developments in technology and trends in veterinary medicine.

"RxWorks software is designed to facilitate consistency of patient care, enable practice growth, achieve enhanced profitability and optimize professional time, all the while improving the quality of life for patients," said Nathan Basha, Chairman of RxWorks. "Aligning with Henry Schein, a global company committed to serving animal health professionals and bringing innovation to the marketplace, allows RxWorks to provide even further value to customers while expanding industry reach."

About Henry Schein, Inc.
Henry Schein, Inc. (NASDAQ:HSIC) is the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners. The Company also serves dental laboratories, government and institutional health care clinics, and other alternate care sites. A Fortune 500® Company and a member of the S&P 500® and the NASDAQ 100® indexes, Henry Schein employs more than 18,000 Team Schein Members and serves more than one million customers.

The Company offers a comprehensive selection of products and services, including value-added solutions for operating efficient practices and delivering high-quality care. Henry Schein operates through a centralized and automated distribution network, with a selection of more than 100,000 branded products and Henry Schein private-brand products in stock, as well as more than 150,000 additional products available as special-order items. The Company also offers its customers exclusive, innovative technology solutions, including practice management software and e-commerce solutions, as well as a broad range of financial services.

Headquartered in Melville, N.Y., Henry Schein has operations or affiliates in 33 countries. The Company's sales reached a record $10.4 billion in 2014, and have grown at a compound annual rate of approximately 16 percent since Henry Schein became a public company in 1995. For more information, visit Henry Schein at www.henryschein.com, Facebook.com/HenrySchein and @HenrySchein on Twitter.

Cautionary Note Regarding Forward-Looking Statements
In accordance with the "Safe Harbor" provisions of the Private Securities Litigation Reform Act of 1995, we provide the following cautionary remarks regarding important factors that, among others, could cause future results to differ materially from the forward-looking statements, expectations and assumptions expressed or implied herein.  All forward-looking statements made by us are subject to risks and uncertainties and are not guarantees of future performance.  These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance and achievements or industry results to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements.  These statements are identified by the use of such terms as "may," "could," "expect," "intend," "believe," "plan," "estimate," "forecast," "project," "anticipate" or other comparable terms.

Risk factors and uncertainties that could cause actual results to differ materially from current and historical results include, but are not limited to: effects of a highly competitive market; our dependence on third parties for the manufacture and supply of our products; our dependence upon sales personnel, customers, suppliers and manufacturers; our dependence on our senior management; fluctuations in quarterly earnings; risks from expansion of customer purchasing power and multi-tiered costing structures; possible increases in the cost of shipping our products or other service issues with our third-party shippers; general global macroeconomic conditions; disruptions in financial markets; possible volatility of the market price of our common stock; changes in the health care industry; implementation of health care laws; failure to comply with regulatory requirements and data privacy laws; risks associated with our global operations; transitional challenges associated with acquisitions and joint ventures, including the failure to achieve anticipated synergies; financial risks associated with acquisitions and joint ventures; litigation risks; the dependence on our continued product development, technical support and successful marketing in the technology segment; risks from challenges associated with the emergence of potential increased competition by third-party online commerce sites; risks from disruption to our information systems; cyberattacks or other privacy or data security breaches; certain provisions in our governing documents that may discourage third-party acquisitions of us; and changes in tax legislation. The order in which these factors appear should not be construed to indicate their relative importance or priority.

We caution that these factors may not be exhaustive and that many of these factors are beyond our ability to control or predict.  Accordingly, any forward-looking statements contained herein should not be relied upon as a prediction of actual results.  We undertake no duty and have no obligation to update forward-looking statements.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/henry-schein-to-acquire-rxworks-300202935.html

SOURCE Henry Schein, Inc.

Investors, Steven Paladino, Executive Vice President and Chief Financial Officer, steven.paladino@henryschein.com, (631) 843-5500; Carolynne Borders, Vice President, Investor Relations, carolynne.borders@henryschein.com, (631) 390-8105; Media, Susan Vassallo, Vice President, Corporate Communications, susan.vassallo@henryschein.com, (631) 843-5562